Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-05

Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Parkinson's Disease

View source ↗

Summary

A pilot study from ProgenaBiome investigating the role of gut flora in Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProgenaBiome

Snippet

Sponsor: ProgenaBiome | Conditions: Parkinson Disease, Parkinsons Disease With Dementia | Status: WITHDRAWN